EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Canagliflozin Inhibits Electrogenic Na+ Transport in Mouse Cortical Collecting Duct Cells

Andrew J Nickerson iD, Wafaa N Albalawy, Elynna B Youm, Nicole A Joseph, Kennedy G Szekely, Thomas R Kleyman, Ora A Weisz, Ossama B Kashlan iD

Function · 2025

DOI: 10.1093/function/zqaf039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Function, 2025. Verfasst von Andrew J Nickerson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Kidney Tubules, Collecting, Canagliflozin, Sodium, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, American Society of Nephrology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) exhibit cardiorenal protective effects that likely involve mechanisms aside from SGLT2 inhibition. Still, many details surrounding these clinically important pleiotropic effects remain unclear. We previously showed that several SGLT2-independent proximal tubular transport functions are inhibited by canagliflozin, but not empagliflozin. Here, we demonstrate a canagliflozin-specific reduction in Sgk1 abundance in both opossum kidney proximal tubule and mouse cortical collecting duct (mCCDcl1) cells, pointing to a possible underlying mechanism. Given the role of Sgk1 in the distal nephron, we hypothesized that canagliflozin would also inhibit epithelial Na+ channel (ENaC)-dependent Na+ transport. Canagliflozin inhibited ENaC-dependent Na+ transport (amiloride-sensitive short circuit current; ISC) in mCCDcl1 cells while empagliflozin had no effect. Selective membrane permeabilization revealed canagliflozin-induced inhibition of both apical conductance through ENaC and basolateral transport via the Na+/K+ ATPase. These effects were mimicked by the selective Sgk1 inhibitor, GSK650394. Surface labeling studies demonstrated reduced membrane localization of ENaC, but not Na+/K+ ATPase subunits, consistent with a mechanism involving Sgk1. Canagliflozin reduced ISC in the presence and absence of rotenone, suggesting inhibition occurs independently of effects on mitochondrial complex I, another known target of canagliflozin. ENaC activity in mouse distal colon was also inhibited by canagliflozin, confirming these effects in native tissue. We identify Na+ transport through ENaC and the Na+/K+ ATPase as novel targets of inhibition by canagliflozin, with Sgk1 as a likely upstream mechanistic component. Canagliflozin-specific effects on transport mediated via this mechanism may contribute to non-class effects of this drug observed clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Tubules, CollectingCanagliflozinSodiumSodium-Glucose Transporter 2 InhibitorsAnimalsMiceProtein Serine-Threonine KinasesImmediate-Early ProteinsEpithelial Sodium ChannelsIon TransportCell LineKidney Tubules, ProximalSerum-Glucocorticoid Regulated Kinases

Stichwörter der Autor:innen

ENaCSGLT2ialdosteroneepitheliumkidneytransport

Substanzen

CanagliflozinSodiumProtein Serine-Threonine KinasesImmediate-Early ProteinsSodium-Glucose Transporter 2 InhibitorsEpithelial Sodium ChannelsSerum-Glucocorticoid Regulated Kinases

Autor:innen und Institutionen

  • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  • Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  • Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  • Department of Pharmacology and Chemical Biology, Pittsburgh, PA 15261, USA.
  • Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15213, USA.

ORCID-Profile: Andrew J Nickerson, Ossama B Kashlan

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • American Society of Nephrology
  • NHLBI NIH HHS
  • NIA NIH HHS
  • Saudi Ministry of Education
  • National Institutes of Health

Zitieren

APA

Nickerson, A. J., Albalawy, W. N., Youm, E. B., Joseph, N. A., Szekely, K. G., Kleyman, T. R., Weisz, O. A., & Kashlan, O. B. (2025). Canagliflozin Inhibits Electrogenic Na+ Transport in Mouse Cortical Collecting Duct Cells. Function. https://doi.org/10.1093/function/zqaf039

Vancouver

Nickerson AJ, Albalawy WN, Youm EB, Joseph NA, Szekely KG, Kleyman TR, et al. Canagliflozin Inhibits Electrogenic Na+ Transport in Mouse Cortical Collecting Duct Cells. Function. 2025. doi:10.1093/function/zqaf039

BibTeX
@article{Nickerson2025,
  author = {Nickerson, Andrew J and Albalawy, Wafaa N and Youm, Elynna B and Joseph, Nicole A and Szekely, Kennedy G and Kleyman, Thomas R and Weisz, Ora A and Kashlan, Ossama B},
  title = {Canagliflozin Inhibits Electrogenic Na+ Transport in Mouse Cortical Collecting Duct Cells},
  journal = {Function},
  year = {2025},
  doi = {10.1093/function/zqaf039}
}
Kostenlos starten →